CE:NYE-Celanese Corporation (USD)

COMMON STOCK | Chemicals |

Last Closing

USD 52.76

Change

+0.15 (+0.29)%

Market Cap

N/A

Volume

5.33M

Analyst Target

USD 110.50
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Chemicals

Symbol Name Price(Change) Market Cap
HUN Huntsman Corporation

-0.18 (-1.01%)

USD 2.94B
BAK Braskem SA Class A

-0.15 (-3.29%)

USD 2.22B
TROX Tronox Holdings PLC

-0.24 (-2.97%)

USD 1.24B
WLKP Westlake Chemical Partners LP

+0.08 (+0.33%)

USD 0.83B
ASIX AdvanSix Inc

+0.46 (+1.57%)

USD 0.79B
VHI Valhi Inc

-0.26 (-1.39%)

USD 0.56B
RYAM Rayonier Advanced Materials

+0.30 (+4.24%)

USD 0.48B
LXU Lsb Industries Inc

-0.28 (-3.56%)

N/A
DOW Dow Inc

-0.08 (-0.20%)

N/A
REX REX American Resources Corpora..

-0.42 (-1.01%)

N/A

ETFs Containing CE

RSPM Invesco S&P 500 Equal Wei.. 3.91 % 0.00 %

-0.60 (-1.79%)

USD 0.21B
PUD.B:CA 1.88 % 0.66 %

N/A

N/A
HRES:CA 0.00 % 1.50 %

N/A

N/A
SZNE Pacer CFRA-Stovall Equal .. 0.00 % 0.60 %

-0.87 (-1.79%)

USD 0.03B
WNDY:LSE Global X Wind Energy UCIT.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -23.77% 10% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -23.77% 10% F 3% F
Trailing 12 Months  
Capital Gain -64.68% 9% A- 2% F
Dividend Return 1.41% 14% F 24% F
Total Return -63.27% 9% A- 2% F
Trailing 5 Years  
Capital Gain -51.14% 18% F 10% F
Dividend Return 11.97% 29% F 39% F
Total Return -39.17% 18% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain 10.97% 45% F 66% D+
Dividend Return 13.12% 27% F 66% D+
Total Return 2.15% 38% F 50% F
Risk Return Profile  
Volatility (Standard Deviation) 40.93% 64% D 24% F
Risk Adjusted Return 32.05% 36% F 46% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.